HER2 overexpressing breast cancer
HER2 overexpressing breast cancer: novel therapeutic strategies
Natural history of HER2-positive disease has changed dramatically over the last 10 years with the advent of HER2-targeted therapies.
This has resulted in HER2-positive early-stage disease becoming a highly curable disease
We have now quite specific areas of need which we have learnt from other studies:
- CNS disease
- Cancers with Pi3K pathway alterations
- Low HER2 expression and
- Low levels of immune infiltrates
- ER status
A review of some of these studies is presented
This event is sponsored by: :
Sherene Loi MBBS (Hons), PhD, FRACP, FAHMS
Medical Oncologist and & Head, Breast Cancer ...
Melbourne, VICTORIA, Australia
Professor Sherene Loi's research interest is to translate interesting scientific findings into innovative treatment approaches.